Insulin in the adjuvant breast cancer setting: A novel therapeutic target for lifestyle and pharmacologic interventions?

Journal of Clinical Oncology

Volumn 26, Issue 6, 2008, Pages 833-834

  Goodwin, Pamela J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; BINDING PROTEIN; C PEPTIDE; ESTROGEN RECEPTOR; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METFORMIN; OCTREOTIDE; SOMATOMEDIN B; SOMATOMEDIN C; TAMOXIFEN; ANTIDIABETIC AGENT; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE;

ADJUVANT THERAPY; BREAST CANCER; CANCER SUSCEPTIBILITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; EXERCISE; FAT INTAKE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIFESTYLE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BINDING; WEIGHT REDUCTION; BLOOD; BREAST TUMOR; ENDURANCE; FEMALE; METABOLISM; MUSCLE STRENGTH; NOTE; RISK FACTOR; SURVIVAL RATE;

BREAST NEOPLASMS; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE; METFORMIN; MUSCLE STRENGTH; PHYSICAL ENDURANCE; PROTEIN KINASES; RISK FACTORS; SURVIVAL RATE;

EID: 39749165365     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.7132     Document Type: Editorial

References (22)

1. Yee D: Targeting insulin-like growth factor pathways. Br J Cancer 94:465-468, 2006
2. Del Giudice ME, Fantus IG, Ezzat S, et al: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120, 1998
3. Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: A meta-analysis. Int J Cancer 121:856-862, 2007
4. Goodwin PJ, Ennis M, Pritchard KI, et al: Fasting insulin and outcome in early stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002
5. Pasanisi P, Berrino F, De Petris M, et al: Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236-238, 2006
6. Pollak MN, Chapman JW, Shepherd L, et al: Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial. J Clin Oncol 24:9s, 2006 (suppl 18S; abstr 524)
7. Chlebowski RT, Aiello E, McTiernan A: Weight loss in breast cancer patient management. J Clin Oncol 20:1128-1143, 2002
8. Meyerhardt JA, Heseltine D, Niedzwiecki, et al: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Clin Oncol 24:3535-3541, 2006
9. Frasca F, Pandini G, Vigneri R, et al: Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells. Breast Dis 17:73-89, 2003
10. Papa V, Belfiore A: Insulin receptors in breast cancer: Biological and clinical role. Endocrinol Invest 19:324-333, 1996
11. Mulligan AM, O'Malley FP, Ennis M, et al: Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat 106:39-47, 2007
12. Belfiore A: The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human breast cancer. Curr Pharm Des 13:671-686, 2007
13. Ligibel JA, Campbell N, Partridge A, et al: Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 26:907-912, 2008
14. Schmitz K, Ahmed R, Hannan P, et al: Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin and insulin-like growth factors. Cancer Epidemiol Biomarkers Prev 14:1672-1680, 2005
15. Courneya K, Mackey J, Bell G, et al: Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life outcomes. J Clin Oncol 21:1660-1668, 2003
16. Chlebowski RT, Blackburn GL, Thomson CA, et al: Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98:1767-1776, 2006
17. Pierce JP, Natarajan L, Caan BJ, et al: Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: The Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289-298, 2007
18. Wing RR, Hamman RF, Bray GA, et al: Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 12:1426-1434, 2004
19. Goodwin PJ, Pritchard KI, Fantus IG, et al: Metformin lowers fasting insulin levels in hyperinsulinemia early stage breast cancer patients: Results of a phase II study. Breast Cancer Res Treat 100:S109, 2006 (suppl 1, abstr 2085)
20. Evans JM, Donnelly LA, Emslie-Smith AM, et al: Metformin and reduced risk of cancer in diabetic patients. BMJ 330:1304-1305, 2005
21. Bowker SL, Majumdar SR, Veugelers P, et al: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29:254-258, 2006
22. Zakikhani M, Dowling R, Fantus, et al: Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res 66:10269-10273, 2006